CLINICAL TRIALS IN CENTER FOR RESPIRATORY MEDICINE

Overview of open clinical trials in Centre for Respiratory Medicine 2017
  • A randomised, double-blind, placebo-controlled study to evaluate the safety, efficacy and changes in induced sputum and blood biomarkers following daily repeat doses of inhaled GSK2269557 for 12 weeks in adult subjects diagnosed with an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
  • An exploratory, randomized, double-blind, placebo-controlled study of the effects of dupilumab on airway inflammation of adults with persistent asthma.
NEXT contact person for respiratory medicine

Camilla Hauge

E-mail: cha@nextpartnership.dk